Literature DB >> 10406330

Cardiovascular morbidity in obstructive sleep apnea.

J W Weiss1, S H Launois, A Anand, E Garpestad.   

Abstract

The repetitive respiratory events that characterize obstructive sleep apnea (OSA) are each followed by abrupt increases in heart rate and in pulmonary and systemic artery pressure and by sudden decreases in right and left ventricular stroke volume. The changes in systemic pressure may be profound, with patients who are normotensive while awake having systolic pressures approaching 300 mm Hg after apnea termination. Because of these dramatic hemodynamic oscillations during sleep, many clinicians and investigators have postulated a connection between sleep-disordered breathing and cardiovascular morbidity and even mortality. This review critically examines the evidence for such a causal relationship. We begin, however, by reviewing the normal hemodynamic changes that occur during sleep. We then describe the acute hemodynamic events associated with OSA. Finally, we summarize the evidence for and against a causal connection between sleep apnea and cardiovascular morbidity.

Entities:  

Mesh:

Year:  1999        PMID: 10406330     DOI: 10.1053/pcad.1999.0410367

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  16 in total

1.  Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy.

Authors:  R Schulz; D Schmidt; A Blum; X Lopes-Ribeiro; C Lücke; K Mayer; H Olschewski; W Seeger; F Grimminger
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

2.  Intestinal malabsorption as a manifestation of obstructive sleep apnea.

Authors:  Tamsin A Knox; Tawhid Gazi; Fay Kastrinos; Alexander C White
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Importance of laboratory parameters in patients with obstructive sleep apnea and their relationship with cardiovascular diseases.

Authors:  Tulay Kıvanc; Sevsen Kulaksızoglu; Huseyin Lakadamyalı; Fusun Eyuboglu
Journal:  J Clin Lab Anal       Date:  2017-03-27       Impact factor: 2.352

Review 4.  Interactions between obstructive sleep apnea and the metabolic syndrome.

Authors:  Anna Svatikova; Robert Wolk; Apoor S Gami; Michal Pohanka; Virend K Somers
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

5.  Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease.

Authors:  Asiye Kanbay; Hakan Buyukoglan; Nezihe Ozdogan; Elif Kaya; Fatma Sema Oymak; Inci Gulmez; Ramazan Demir; Oguz Kokturk; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-03       Impact factor: 2.370

6.  Mandibular advancement splint titration in obstructive sleep apnoea.

Authors:  A J Campbell; G Reynolds; H Trengrove; A M Neill
Journal:  Sleep Breath       Date:  2008-11-07       Impact factor: 2.816

7.  Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome.

Authors:  Jing Ma; Yongjian Xu; Zhenxiang Zhang; Huiguo Liu; Weining Xiong; Shuyun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

8.  Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Handan Inonu Koseoglu; Fatih Altunkas; Asiye Kanbay; Sibel Doruk; Ilker Etikan; Osman Demir
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

9.  Risk of Obstructive Sleep Apnea in Adult Patients with Asthma: A Population-Based Cohort Study in Taiwan.

Authors:  Te-Chun Shen; Cheng-Li Lin; Chang-Ching Wei; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Fung-Chang Sung; Chia-Hung Kao
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 10.  Sleep apnea and atrial fibrillation; 2012 update.

Authors:  Genevieve C Digby; Adrian Baranchuk
Journal:  Curr Cardiol Rev       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.